Literature DB >> 23199400

Prevention of influenza in healthy children.

Bruce Y Lee1, Mirat Shah.   

Abstract

Healthy children are high transmitters of influenza and can experience poor influenza outcomes. Many questions remain about the efficacy and impect of preventive measures because most existing studies report imprecise proxies of influenza incidence, do not follow subjects throughout the entire influenza season and across multiple influenza seasons, or do not control for important factors such as timing of implementation and social contact patterns. Modeling and simulation are key methodologies to answer questions regarding influenza prevention. While vaccination may be the most efficacious existing intervention, variations in circulating strains and children's immune systems keep current vaccines from being fully protective, necessitating further clinical and economic studies and technology improvements. Hand hygiene appears to be an important adjunct but improving compliance, standardizing regimens and quantifying its impact remain challenging. Future studies should help better define the specific indications and circumstances for antiviral use and the role of nutritional supplements and nonpharmaceutical interventions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23199400      PMCID: PMC3763239          DOI: 10.1586/eri.12.106

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  114 in total

1.  Risk factors for laboratory-confirmed household transmission of pandemic H1N1 2009 infection.

Authors:  Dong Hoon Lee; Chan Woong Kim; Ji-Hyun Kim; Jong Seung Lee; Mi Kyung Lee; Jae Chol Choi; Byoung Whui Choi; Seong-Ho Choi; Jin-Won Chung
Journal:  Am J Infect Control       Date:  2010-12       Impact factor: 2.918

2.  Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England.

Authors:  A Wallensten; I Oliver; D Lewis; S Harrison
Journal:  Euro Surveill       Date:  2009-07-30

3.  Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

Authors:  Simon J Hambidge; Jason M Glanz; Eric K France; David McClure; Stanley Xu; Kristi Yamasaki; Lisa Jackson; John P Mullooly; Kenneth M Zangwill; S Michael Marcy; Steven B Black; Edwin M Lewis; Henry R Shinefield; Edward Belongia; James Nordin; Robert T Chen; David K Shay; Robert L Davis; Frank DeStefano
Journal:  JAMA       Date:  2006-10-25       Impact factor: 56.272

4.  Economic value of norovirus outbreak control measures in healthcare settings.

Authors:  B Y Lee; Z S Wettstein; S M McGlone; R R Bailey; C A Umscheid; K J Smith; R R Muder
Journal:  Clin Microbiol Infect       Date:  2010-10-26       Impact factor: 8.067

5.  Safety of the trivalent inactivated influenza vaccine among children: a population-based study.

Authors:  Eric K France; Jason M Glanz; Stanley Xu; Robert L Davis; Steven B Black; Henry R Shinefield; Kenneth M Zangwill; S Michael Marcy; John P Mullooly; Lisa A Jackson; Robert Chen
Journal:  Arch Pediatr Adolesc Med       Date:  2004-11

6.  Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S.

Authors:  Sandra E Talbird; Anita J Brogan; Aleksander P Winiarski
Journal:  Am J Prev Med       Date:  2009-11       Impact factor: 5.043

7.  Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study.

Authors:  Herman A Cohen; Itzchak Varsano; Ernesto Kahan; E Michael Sarrell; Yosef Uziel
Journal:  Arch Pediatr Adolesc Med       Date:  2004-03

8.  Effects of school closures, 2008 winter influenza season, Hong Kong.

Authors:  Benjamin J Cowling; Eric H Y Lau; Conrad L H Lam; Calvin K Y Cheng; Jana Kovar; Kwok Hung Chan; J S Malik Peiris; Gabriel M Leung
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

9.  Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza.

Authors:  Joel K Kelso; George J Milne; Heath Kelly
Journal:  BMC Public Health       Date:  2009-04-29       Impact factor: 3.295

Review 10.  Closure of schools during an influenza pandemic.

Authors:  Simon Cauchemez; Neil M Ferguson; Claude Wachtel; Anders Tegnell; Guillaume Saour; Ben Duncan; Angus Nicoll
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

View more
  3 in total

1.  Quantifying the economic value and quality of life impact of earlier influenza vaccination.

Authors:  Bruce Y Lee; Sarah M Bartsch; Shawn T Brown; Philip Cooley; William D Wheaton; Richard K Zimmerman
Journal:  Med Care       Date:  2015-03       Impact factor: 2.983

Review 2.  The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach.

Authors:  Giovanna Elisa Calabro'; Elettra Carini; Alessia Tognetto; Irene Giacchetta; Ester Bonanno; Marco Mariani; Walter Ricciardi; Chiara de Waure
Journal:  Front Public Health       Date:  2022-03-09

Review 3.  Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency.

Authors:  Thamina Acter; Nizam Uddin; Jagotamoy Das; Afroza Akhter; Tasrina Rabia Choudhury; Sunghwan Kim
Journal:  Sci Total Environ       Date:  2020-04-30       Impact factor: 7.963

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.